symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NXEN,0.0261,1.492913,11332,1690554,0,0.021-0.1,0.0021,"Nexien BioPharma, Inc.",USD,0001625288,,81577F109,Other OTC,PNK,Drug Manufacturersâ€”Specialty & Generic,https://www.nexienbiopharma.com,"Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.",Mr. Richard S. Greenberg,Healthcare,US,,303 495 7583,4340 East Kentucky Avenue,Glendale,CO,80246,,0,https://financialmodelingprep.com/image-stock/NXEN.png,2017-11-29,False,False,True,False,False
